These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7795831)

  • 1. Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Hebert PR; Bolt RJ; Borhani NO; Cook NR; Cohen JD; Cutler JA; Hollis JF; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1995 Mar; 5(2):130-9. PubMed ID: 7795831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Lasser VI; Raczynski JM; Stevens VJ; Mattfeldt-Beman MK; Kumanyika S; Evans M; Danielson E; Dalcin A; Batey DM; Belden LK
    Ann Epidemiol; 1995 Mar; 5(2):156-64. PubMed ID: 7795834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Appel LJ; Hebert PR; Cohen JD; Obarzanek E; Yamamoto M; Buring J; Stevens V; Kirchner K; Borhani NO
    Ann Epidemiol; 1995 Mar; 5(2):149-55. PubMed ID: 7795833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trials of hypertension prevention. Phase I design.
    Satterfield S; Cutler JA; Langford HG; Applegate WB; Borhani NO; Brittain E; Cohen JD; Kuller LH; Lasser NL; Oberman A
    Ann Epidemiol; 1991 Aug; 1(5):455-71. PubMed ID: 1669525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial.
    Appel LJ; Espeland M; Whelton PK; Dolecek T; Kumanyika S; Applegate WB; Ettinger WH; Kostis JB; Wilson AC; Lacy C
    Ann Epidemiol; 1995 Mar; 5(2):119-29. PubMed ID: 7795830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group.
    Stevens VJ; Corrigan SA; Obarzanek E; Bernauer E; Cook NR; Hebert P; Mattfeldt-Beman M; Oberman A; Sugars C; Dalcin AT
    Arch Intern Med; 1993 Apr; 153(7):849-58. PubMed ID: 8466377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.
    Stevens VJ; Obarzanek E; Cook NR; Lee IM; Appel LJ; Smith West D; Milas NC; Mattfeldt-Beman M; Belden L; Bragg C; Millstone M; Raczynski J; Brewer A; Singh B; Cohen J;
    Ann Intern Med; 2001 Jan; 134(1):1-11. PubMed ID: 11187414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I.
    JAMA; 1992 Mar; 267(9):1213-20. PubMed ID: 1586398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
    Hollis JF; Satterfield S; Smith F; Fouad M; Allender PS; Borhani N; Charleston J; Hirlinger M; King N; Schultz R
    Ann Epidemiol; 1995 Mar; 5(2):140-8. PubMed ID: 7795832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.
    Juraschek SP; Miller ER; Weaver CM; Appel LJ
    J Am Coll Cardiol; 2017 Dec; 70(23):2841-2848. PubMed ID: 29141784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.
    Appel LJ; Champagne CM; Harsha DW; Cooper LS; Obarzanek E; Elmer PJ; Stevens VJ; Vollmer WM; Lin PH; Svetkey LP; Stedman SW; Young DR;
    JAMA; 2003 Apr 23-30; 289(16):2083-93. PubMed ID: 12709466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.
    Whelton PK; Kumanyika SK; Cook NR; Cutler JA; Borhani NO; Hennekens CH; Kuller LH; Langford H; Jones DW; Satterfield S; Lasser NL; Cohen JD
    Am J Clin Nutr; 1997 Feb; 65(2 Suppl):652S-660S. PubMed ID: 9022561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet.
    Juraschek SP; Woodward M; Sacks FM; Carey VJ; Miller ER; Appel LJ
    Hypertension; 2017 Nov; 70(5):923-929. PubMed ID: 28993451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
    He J; Whelton PK; Appel LJ; Charleston J; Klag MJ
    Hypertension; 2000 Feb; 35(2):544-9. PubMed ID: 10679495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.
    Davis BR; Blaufox MD; Oberman A; Wassertheil-Smoller S; Zimbaldi N; Cutler JA; Kirchner K; Langford HG
    Arch Intern Med; 1993 Aug; 153(15):1773-82. PubMed ID: 8333814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.